Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia

被引:6
|
作者
Aydemir, Hande [1 ]
Piskin, Nihal [1 ]
Kokturk, Furuzan [2 ]
Gokmen, Ayla [3 ]
Akduman, Deniz [1 ]
机构
[1] Bulent Ecevit Univ, Fac Med, Dept Infect Dis & Clin Microbiol, TR-67600 Zonguldak, Turkey
[2] Bulent Ecevit Univ, Fac Med, Dept Biostat, TR-67600 Zonguldak, Turkey
[3] Bulent Ecevit Univ, Fac Med, Dept Hematol, TR-67600 Zonguldak, Turkey
关键词
Bacteremia; Neutropenia; Malignant; Febrile neutropenia; Elderly; Mortality; BLOOD-STREAM INFECTIONS; MULTINATIONAL ASSOCIATION; SUPPORTIVE CARE; RISK FEBRILE; DEFINITIONS; COHORT;
D O I
10.1016/j.jgo.2012.10.174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this study was to determine the epidemiology, clinical manifestations, and outcome of health-care associated bacteremia in geriatric cancer patients with febrile neutropenia. Materials and Methods: We retrospectively evaluated cancer patients with febrile neutropenia aged >= 60 years with culture proven health-care associated bacteremia between January 2005 and December 2011. The date of the first positive blood culture was regarded as the date of bacteremia onset. Primary outcome was the infection related mortality, defined as the death within 14 days of bacteremia onset. Results: The two most common pathogens responsible for bacteremia were Staphylococcus epidermidis (36.1%) and Escherichia coli (31.5%), with high rates of methicillin resistance and extended-spectrum beta-lactamase (ESBL) production, respectively. There were no statistically significant differences in infection related mortality rate according to the type of malignancy (p=0.776). By the univariate analysis, factors associated with 14 day mortality among febrile neutropenic episodes were prolonged neutropenia (p=0.024), persistent fever (p=0.001), hospitalization in ICU (p<0.001) and the initial clinical presentations including respiratory failure (p<0.001), hepatic failure (p=0.013), hematological failure (p<0.001), neurological failure (p<0.001), severe sepsis (p<0.001), and septic shock (p=0.036). Multivariate analysis showed that persistent fever was an independent factor associated with infection related mortality (odds ratio, 18.0; 95% confidence interval, 5.2-62.6; p<0.001). Conclusions: The only independent risk factor for mortality was persistent fever. Although the most frequently isolated pathogens were S. epidermidis and E. coli, high rates of methicillin resistance and ESBL production were found respectively. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:190 / 195
页数:6
相关论文
共 50 条
  • [21] Febrile neutropenia-related care and associated costs in elderly patients with breast cancer, lung cancer, or non-Hodgkin lymphoma
    Li, Shuling
    Liu, Jiannong
    Bowers, Charles
    Garawin, Tamer A. F. S.
    Kim, Christopher
    Bensink, Mark E.
    Chandler, David B.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (01) : 113 - 122
  • [22] Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer
    Fletcher, Matthew
    Hodgkiss, Hailey
    Zhang, Song
    Browning, Rachel
    Hadden, Colleen
    Hoffman, Tanja
    Winick, Naomi
    McCavit, Timothy L.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (08) : 1299 - 1306
  • [23] Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy
    Ha, Young Eun
    Song, Jae-Hoon
    Kang, Won Ki
    Peck, Kyong Ran
    Chung, Doo Ryeon
    Kang, Cheol-In
    Joung, Mi-Kyong
    Joo, Eun-Jeong
    Shon, Kyung Mok
    SUPPORTIVE CARE IN CANCER, 2011, 19 (11) : 1761 - 1767
  • [24] LACK OF ASSOCIATION BETWEEN NEUTROPENIA AND THE INCIDENCE OF BACTEREMIA ASSOCIATED WITH INDWELLING CENTRAL VENOUS CATHETERS IN FEBRILE PEDIATRIC CANCER-PATIENTS
    GORELICK, MH
    OWEN, WC
    SEIBEL, NL
    REAMAN, GH
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (07) : 506 - 510
  • [25] Cefepime monotherapy for febrile neutropenia in patients with lung cancer
    Saito, Hiroshi
    Takahashi, Kosuke
    Okuno, Motoyasu
    Saka, Hideo
    Imaizumi, Kazuyoshi
    Hasegawa, Yoshinori
    Tanikawa, Yoshimasa
    Yamamoto, Masashi
    Taniguchi, Hiroyuki
    Shindoh, Joe
    Suzuki, Ryujiro
    Shimokata, Kaoru
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (5-6) : 365 - 369
  • [26] Febrile neutropenia in cancer patients: management in the emergency room
    Rivera-Salgado, Daniel
    Valverde-Munoz, Kathia
    Avila-Aguero, Maria L.
    REVISTA CHILENA DE INFECTOLOGIA, 2018, 35 (01): : 62 - 71
  • [27] PREVALENCE OF PATHOGENS IN PEDIATRIC CANCER PATIENTS WITH FEBRILE NEUTROPENIA
    Vathana, Nassawee
    Thitipolpun, Siriporn
    Buaboonnam, Jassada
    Phuakpet, Kamon
    Sanpakit, Kleebsabai
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2017, 48 : 151 - 160
  • [28] The Microbiologic Pattern in Pediatric Cancer Patients with Febrile Neutropenia and Bacteremia: A Referral Hospital-Based Study in Northwest of Iran
    Rezaee, Mohammad Ahangarzadeh
    Abdinia, Babak
    Delpak, Ata
    Rezamand, Azim
    IRANIAN JOURNAL OF PEDIATRICS, 2017, 27 (02)
  • [29] Monitoring Neutropenia for Cancer Patients at the Point of Care
    Inan, Hakan
    Kingsley, James L.
    Ozen, Mehmet O.
    Tekin, Huseyin Cumhur
    Hoerner, Christian R.
    Imae, Yoriko
    Metzner, Thomas J.
    Preiss, Jordan S.
    Durmus, Naside Gozde
    Ozsoz, Mehmet
    Wakelee, Heather
    Fan, Alice C.
    Tuzel, Erkan
    Demirci, Utkan
    SMALL METHODS, 2017, 1 (09):
  • [30] Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus
    Keiser, P
    Higgs, E
    Smith, J
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1996, 312 (03) : 118 - 122